CS logo
small CS logo
Oncology Institute of Vojvodina

Sremska Kamenica, Serbia
Cancer treatment center in Sremska Kamenica
Put doktora Goldmana 4, Sremska Kamenica 21204

About Oncology Institute of Vojvodina


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
10
Pfizer
3
Aileron Therapeutics, Inc.
1
Arbeitsgemeinschaft medikamentoese Tumortherapie
1
Can-Fite BioPharma
1
Central European Cooperative Oncology Group
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Helsinn Healthcare SA
1
ImmunoVaccine Technologies, Inc. (IMV Inc.)
1
Infinity Pharmaceuticals, Inc.
1
Light Sciences Oncology
1
Total Rows: 15

Clinical Trials at Oncology Institute of Vojvodina


During the past decade, Oncology Institute of Vojvodina conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years332211221111221122110022442222000000Started TrialsCompleted Trails2015201620172018201920202021202220230246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
2001-04-04
2037-12-01
Active, not recruiting
232
Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer
2006-06-01
Completed
33
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
2006-01-01
2013-03-01
Completed
683
Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases
2007-02-01
2011-10-01
Completed
483
2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
2008-04-01
2014-12-01
Completed
564
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
2011-03-01
2018-06-01
Completed
101
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436

Rows per page:

1–26 of 26

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncology Institute of Vojvodina" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Pfizer" with 3 trials sponsored, "Aileron Therapeutics, Inc." with 1 trials sponsored, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored and "Can-Fite BioPharma" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Institute of Vojvodina" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "European Society of Surgical Oncology" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 10Hoffmann-La Roche: 10Pfizer: 3Pfizer: 3Aileron Therapeutics, Inc.: 1Aileron Therapeutics, Inc.: 1ArbeitsgemeinschaftmedikamentoeseTumortherapie: 1ArbeitsgemeinschaftmedikamentoeseTumortherapie: 1Can-Fite BioPharma: 1Can-Fite BioPharma: 1Central EuropeanCooperative OncologyGroup: 1Central EuropeanCooperative OncologyGroup: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Helsinn Healthcare SA: 1Helsinn Healthcare SA: 1ImmunoVaccineTechnologies, Inc. (IMVInc.): 1ImmunoVaccineTechnologies, Inc. (IMVInc.): 1Infinity Pharmaceuticals, Inc.: 1Infinity Pharmaceuticals, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsBristol-Myers Squibb: 1Bristol-Myers Squibb: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Society ofSurgical Oncology: 1European Society ofSurgical Oncology: 1German Breast Group: 1German Breast Group: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1PSI CRO: 1PSI CRO: 1

Clinical Trials Conditions at Oncology Institute of Vojvodina


According to Clinical.Site data, the most researched conditions in "Oncology Institute of Vojvodina" are "Metastatic Breast Cancer" (3 trials), "Bladder Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Melanoma" (2 trials) and "Urothelial Carcinoma" (2 trials). Many other conditions were trialed in "Oncology Institute of Vojvodina" in a lesser frequency.

Clinical Trials Intervention Types at Oncology Institute of Vojvodina


Most popular intervention types in "Oncology Institute of Vojvodina" are "Drug" (21 trials), "Other" (4 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (3 trials), "Paclitaxel" (3 trials), "Carboplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Oncology Institute of Vojvodina


The vast majority of trials in "Oncology Institute of Vojvodina" are 24 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Oncology Institute of Vojvodina


Currently, there are NaN active trials in "Oncology Institute of Vojvodina". 1 are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Oncology Institute of Vojvodina, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Institute of Vojvodina, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 18Phase 3: 18Phase 2: 3Phase 2: 3Phase 1: 1Phase 1: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 14Completed: 14Recruiting: 6Recruiting: 6Active, not recruiting: 4Active, not recruiting: 4Not yet recruiting: 1Not yet recruiting: 1Terminated: 1Terminated: 1

Departments of Oncology Institute of Vojvodina


Oncology Institute of Vojvodina has several departments that took part in Clinical trials: "Institute for Cardiovascular Diseases of Vojvodina" - 17 trials, "Institut za onkologiju Vojvodine" - 2 trials
Departments List
Total Rows: 2